Results 151 to 160 of about 847 (163)

Atogepant/Botulinum-Toxin-A/Fremanezumab

Reactions Weekly
openaire   +1 more source

Atogepant vs. Topiramat in der Migräneprophylaxe

InFo Neurologie + Psychiatrie
openaire   +1 more source

Pharmacokinetics and Safety of Atogepant Co-Administered With Quinidine Gluconate in Healthy Participants: A Phase 1, Open-Label, Drug-Drug Interaction Study

Clinical Pharmacology in Drug Development
Ramesh R Boinpally, Lisa Borbridge
exaly  

Adverse Events Associated With Atogepant: A FAERS-Based Pharmacovigilance Analysis

Expert Opinion on Drug Safety
Yuming Wang
exaly  

Safety and Tolerability of Ubrogepant for the Acute Treatment of Migraine in Participants Taking Atogepant for the Preventive Treatment of Episodic Migraine: Results From the TANDEM Study

Headache
Jessica Ailani, László Mechtler, Andrew M Blumenfeld   +2 more
exaly  

Efficacy and Safety of Atogepant for Preventing Chronic and Episodic Migraines: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Current Treatment Options in Neurology
Francisco Cezar Aquino de Moraes, Lucca Moreira Lopes, Eric Pasqualotto   +2 more
exaly  

Atogepant im Praxisalltag wirtschaftlich verordnen

InFo Neurologie + Psychiatrie
openaire   +1 more source

Episodische Migräne: Atogepant sicher und wirksam?

Fortschritte der Neurologie · Psychiatrie
openaire   +1 more source

How Does Atogepant Compare With Rimegepant for Migraine?

Neurology Today
openaire   +1 more source

Migräneprophylaxe: Atogepant im Praxisalltag wirtschaftlich verordnen

Schmerzmedizin
openaire   +1 more source